SCHEMBL17539709

SCHEMBL17539709

CNc1ccccc1N(C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.40
MAPT P10636 3/20 0.40
TDP1 Q9NUW8 3/20 0.40
EGFR P00533 2/20 0.40
MAPK1 P28482 2/20 0.40
PABPC1 P11940 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTR6 P50406 1/20 0.36
IDO1 P14902 1/20 0.35
ATM Q13315 1/20 0.33
TAAR1 Q96RJ0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18886006 0.84 KDM4E (0.36) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL23312224 0.82 AOC1 (0.44) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL20830555 0.78 MAPT (0.44) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL6568199 0.78 KDM1A (0.47) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL31718394 0.78 KDM1A (0.47) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL17850566 0.74 MAPT (0.41) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL27647094 0.74 MAPT (0.41) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL19194548 0.73 MAPT (0.45) L3MBTL1MAPTTDP1EGFRMAPK1
SCHEMBL16838878 0.72 NUDT1 (0.39) HTR6NR3C1SLC6A2SLC6A4
SCHEMBL24498368 0.72 KMT2A (0.51) L3MBTL1MAPTTDP1EGFRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION AOC2, AZI2, KCNH2 L3MBTL1 997/4885MAPT 4371/4885TDP1 4351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.